BACKGROUND: Impaired exercise capacity is one of the hallmarks of heart failure with preserved ejection fraction (HFpEF), but the clinical and hemodynamic correlates and prognostic value of exercise testing in patients with HFpEF is unknown. METHODS: Patients with HFpEF (left ventricular ejection fraction [LVEF] ≥45%) and pulmonary hypertension underwent cardiopulmonary exercise test (CPX) to measure maximal (peak VO2) and submaximal (ventilatory equivalent for carbon dioxide [VE/VCO2] slope) exercise capacity. In addition, right heart catheterization was performed. Patients were grouped in tertiles based on the VE/VCO2 slope. Univariate and multivariate regression analyses were performed. A Cox regression analysis was performed to determine the mortality during follow-up. RESULTS: We studied 88 patients: mean age 73 ± 9 years, 67% female, mean LVEF 58%, median N-terminal pro-B-type natriuretic peptide (NT-proBNP) 840 (interquartile range 411-1938) ng/L. Patients in the highest VE/VCO2 tertile had the most severe HF, as reflected in higher New York Heart Association functional class and higher NT-proBNP plasma levels (all P < .05 for trend), whereas LVEF was similar between the groups. Multivariable regression analysis with backward elimination on invasive hemodynamic measurements showed that VE/VCO2 slope was independently associated with pulmonary vascular resistance (PVR). Cox regression analysis showed that increased VE/VCO2 slope (but not peak VO2) was independently associated with increased mortality. CONCLUSION: Increased VE/VCO2 slope was associated with more severe disease and higher PVR and was independently associated with increased mortality in patients with HFpEF.
BACKGROUND: Impaired exercise capacity is one of the hallmarks of heart failure with preserved ejection fraction (HFpEF), but the clinical and hemodynamic correlates and prognostic value of exercise testing in patients with HFpEF is unknown. METHODS:Patients with HFpEF (left ventricular ejection fraction [LVEF] ≥45%) and pulmonary hypertension underwent cardiopulmonary exercise test (CPX) to measure maximal (peak VO2) and submaximal (ventilatory equivalent for carbon dioxide [VE/VCO2] slope) exercise capacity. In addition, right heart catheterization was performed. Patients were grouped in tertiles based on the VE/VCO2 slope. Univariate and multivariate regression analyses were performed. A Cox regression analysis was performed to determine the mortality during follow-up. RESULTS: We studied 88 patients: mean age 73 ± 9 years, 67% female, mean LVEF 58%, median N-terminal pro-B-type natriuretic peptide (NT-proBNP) 840 (interquartile range 411-1938) ng/L. Patients in the highest VE/VCO2 tertile had the most severe HF, as reflected in higher New York Heart Association functional class and higher NT-proBNP plasma levels (all P < .05 for trend), whereas LVEF was similar between the groups. Multivariable regression analysis with backward elimination on invasive hemodynamic measurements showed that VE/VCO2 slope was independently associated with pulmonary vascular resistance (PVR). Cox regression analysis showed that increased VE/VCO2 slope (but not peak VO2) was independently associated with increased mortality. CONCLUSION: Increased VE/VCO2 slope was associated with more severe disease and higher PVR and was independently associated with increased mortality in patients with HFpEF.
Authors: Adam W Powell; Tarek Alsaied; Omar Niss; Robert J Fleck; Punam Malik; Charles T Quinn; Wayne A Mays; Michael D Taylor; Clifford Chin Journal: Pediatr Blood Cancer Date: 2019-03-07 Impact factor: 3.167
Authors: Tarek Alsaied; Omar Niss; Adam W Powell; Robert J Fleck; James F Cnota; Clifford Chin; Punam Malik; Charles T Quinn; Michael D Taylor Journal: Pediatr Blood Cancer Date: 2018-05-21 Impact factor: 3.167
Authors: Matthew Nayor; Vanessa Xanthakis; Melissa Tanguay; Jasmine B Blodgett; Ravi V Shah; Mark Schoenike; John Sbarbaro; Robyn Farrell; Rajeev Malhotra; Nicholas E Houstis; Raghava S Velagaleti; Stephanie A Moore; Aaron L Baggish; George T O'Connor; Jennifer E Ho; Martin G Larson; Ramachandran S Vasan; Gregory D Lewis Journal: Circ Heart Fail Date: 2020-05-04 Impact factor: 8.790
Authors: Jingyi Gong; Renata R T Castro; Jesse P Caron; Camden P Bay; Jon Hainer; Alexander R Opotowsky; Mandeep R Mehra; Bradley A Maron; Marcelo F Di Carli; John D Groarke; Anju Nohria Journal: ESC Heart Fail Date: 2021-12-21
Authors: Marco Guazzi; Barry Borlaug; Marco Metra; Maurizio Losito; Francesco Bandera; Eleonora Alfonzetti; Sara Boveri; Tadafumi Sugimoto Journal: J Am Heart Assoc Date: 2021-02-20 Impact factor: 5.501